Explore evidence

Less than half of individuals reported continuing PrEP at follow-up visits during the early stages of PrEP scale-up in Kenya.

KenyaVIH/sidapublished 2022PloS onePubMeddocument of 3 observations

0.04 pg/μLThe mean plasma aflatoxin B1 concentration for all women living with HIV was 0.0403 pg/μL.

KenyaVIH/sidapublished 2025International journal of STD & AIDSPubMeddocument of 8 observations

18.99 daysBusia County had the longest mean DNA-PCR transport time at 18.99 days in Vihiga, Bungoma, Kakamega and Busia counties in Kenya between January 2012 and June 2013.

KenyaVIH/sidaobserved January 2012 to June 2013published 2024PloS onePubMeddocument of 7 observations

6,175,960 USDTotal economic costs for providing HIV services to key populations were US$6,175,960 in Kenya and US$4,261,207 in Malawi for fiscal year 2019.

Kenya · MalawiVIH/sidaobserved FY2019published 2023Global health, science and practicePubMeddocument of 4 observations

60.4 %Self-reported HIV testing at 3 months was 60.4% in intervention clusters and 10.0% in control clusters.

KenyaVIH/sidapublished 2025The Lancet. Global healthPubMeddocument of 13 observations

1.46 per_100_person_yearsThe crude HIV incidence rate was 1.46 cases per 100 person-years.

KenyaVIH/sidapublished 2025AIDS and behaviorPubMeddocument of 5 observations

182 mothersBetween February and November 2010, 182 mothers were screened for participation in the PedVacc 002 trial.

KenyaVIH/sidaobserved February and November 2010published 2014Vaccineeurope_pmcdocument of 10 observations

61 %Of the 265 adolescents and young adults living with HIV who had perinatally acquired HIV, 162 (61%) were female.

KenyaVIH/sidaobserved 2019published 2023Frontiers in public healthPubMeddocument of 18 observations

58 %Missed opportunities in screening for PrEP eligibility were 58% for female sex workers (FSW).

KenyaVIH/sidaobserved February 2017 to December 2019published 2020Journal of the International AIDS SocietyPubMeddocument of 13 observations

5.7 odds_ratioDetection of HIV-1 RNA was increased when cervical infections were present (adjusted odds ratio 5.7, 95% confidence interval 1.0–30.3, P = 0.04).

Kenyacervical infections · VIH/sidapublished 2010AIDS (London, England)europe_pmcdocument of 4 observationsDOI 10.1097/qad.0b013e32833f9f43

42 %HIV acquisition risk was 42% higher among men who spent some nights away in the past month at baseline.

KenyaVIH/sidapublished 2025AIDS and behavioreurope_pmcdocument of 18 observations

0.58 ratioIn adjusted analyses, HIV prevalence among female sex workers accessing SWOP clinics in Nairobi in 2012 was associated with an adjusted prevalence ratio of 0.58 compared with 2008.

KenyaVIH/sidaobserved 2012published 2021AIDS (London, England)PubMeddocument of 13 observations

2 %Events representing HIV transmission potential, where there was biological evidence of condomless sex at a visit with a detectable plasma viral load, were observed at 2% of visits.

KenyaVIH/sidapublished 2020AIDS and behavioreurope_pmcdocument of 3 observations

97.7 %The total agreement at the medical decision point of 1000 copies/mL between plasma HIV viral load in Abbott RealTime HIV-1 Assay and plasma, finger stick dried blood spots, and venous blood dried blood spots tested in Hologic Aptima HIV-1 Quant Dx Assay were 97.7%, 92.2%, and 95.3%, respectively.

KenyaVIH/sidapublished 2021PloS onePubMeddocument of 3 observations

83 %Most PrEP clients (83%, 575/691) expressed willingness to pay for pharmacy-delivered PrEP services.

KenyaVIH/sidapublished 2025BMC health services researchPubMeddocument of 13 observations

50 copies/mlPersistent low-level viremia (pLLV) was defined as viral load between 50 and 500 copies/ml in HIV-1 participants on first-line cART.

KenyaVIH/sidapublished 2025The Pan African medical journalPubMeddocument of 11 observations

2.2 %The risk of infant HIV acquisition by 24 months of age was 2.2% in 2021.

KenyaVIH/sidaobserved 2021published 2024PLoS medicineeurope_pmcdocument of 5 observations

1.01 relative_riskThe relative risk of HIV testing when offering two HIV self-tests versus one was 1.01.

KenyaVIH/sidaobserved March 2021-June 2022published 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations

Among persons with HIV on long-term antiretroviral therapy, being older than 40 years was associated with hypertension.

Kenyahypertension artérielle · VIH/sidaobserved September 2017 to May 2018published 2022PloS onePubMeddocument of 6 observations

44,780 individualsThe number of active children living with HIV on treatment at the end of US Government fiscal year 2022 was 44,780.

KenyaVIH/sidaobserved FY 2022published 2025The Pediatric infectious disease journalPubMeddocument of 10 observations

79 %79% (n = 379) of the initial cohort (n = 480) were on zidovudine/abacavir + lamivudine + efavirenz/nevirapine for a median duration of 2 years.

KenyaVIH/sidaobserved 2010-2013published 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 13 observations

13 %Among 31 women treated for trichomoniasis, the concentration of vaginal HIV-1 RNA was above the limit for quantitation during infection in 4 women (13%).

Kenyatrichomoniasis · VIH/sidapublished 2011BMC infectious diseaseseurope_pmcdocument of 5 observations

100 %Sensitivity among people living with HIV with suspected tuberculosis was 100% versus sputum Xpert alone.

Kenyatuberculose · VIH/sidapublished 2022PloS onePubMeddocument of 10 observations

64 %Sixty-four percent of female sex workers in Mombasa County, Kenya had tested for HIV within three months.

KenyaVIH/sidapublished 2024The Pan African medical journalPubMeddocument of 6 observations

12.9 %Antiretroviral therapy averted between 12.9% and 39.8% of HIV infections among people who inject drugs in Kenya in 2020 due to suboptimal viral suppression.

KenyaVIH/sidaobserved 2020published 2022AIDS (London, England)PubMeddocument of 8 observations